Letters to the Editor

Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma

Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna, Austria; Recipient of a DOC Fellowship of the Austrian Academy of Sciences at the Wilhelminen Cancer Research Institute
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna
Haematologica Early view Apr 29, 2021 https://doi.org/10.3324/haematol.2020.277152